Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Spiegel

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 24, 2017
Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic IntervalSteven M Brunelli, Charles Du Mond, Nina Oestreicher, et al.
American Journal of Nephrology|October 11, 2017
Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia StudyPablo E Pergola, David M Spiegel, Suzette Warren, et al.
Journal of Nephrology|April 23, 2009
How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?Antonio Bellasi, Laura Kooienga, Geoffrey A Block, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2018
Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral MetabolismDavid A Bushinsky, David M Spiegel, Jinwei Yuan, et al.
Kidney International|September 17, 2005
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysisGeoffrey A Block, David M Spiegel, James Ehrlich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patientsSteven M Brunelli, David M Spiegel, Charles Du Mond, et al.
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|July 7, 2025
The Positive Impact of Patient Education on Tenapanor Adherence in the OPTIMIZE StudyRory C Pace, David P Tietjen, David M Spiegel, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|July 11, 2024
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney FailureKathleen M Hill Gallant, Stuart M Sprague, David P Rosenbaum, et al.
American Journal of Nephrology|October 27, 2016
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on HemodialysisDavid A Bushinsky, Patrick Rossignol, David M Spiegel, et al.
Kidney International Reports|February 19, 2019
Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis PatientsCsaba P Kovesdy, Christopher G Rowan, Ansgar Conrad, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 24, 2017
Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic IntervalSteven M Brunelli, Charles Du Mond, Nina Oestreicher, et al.
American Journal of Nephrology|October 11, 2017
Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia StudyPablo E Pergola, David M Spiegel, Suzette Warren, et al.
Journal of Nephrology|April 23, 2009
How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?Antonio Bellasi, Laura Kooienga, Geoffrey A Block, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2018
Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral MetabolismDavid A Bushinsky, David M Spiegel, Jinwei Yuan, et al.
Kidney International|September 17, 2005
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysisGeoffrey A Block, David M Spiegel, James Ehrlich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patientsSteven M Brunelli, David M Spiegel, Charles Du Mond, et al.
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|July 7, 2025
The Positive Impact of Patient Education on Tenapanor Adherence in the OPTIMIZE StudyRory C Pace, David P Tietjen, David M Spiegel, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|July 11, 2024
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney FailureKathleen M Hill Gallant, Stuart M Sprague, David P Rosenbaum, et al.
American Journal of Nephrology|October 27, 2016
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on HemodialysisDavid A Bushinsky, Patrick Rossignol, David M Spiegel, et al.
Kidney International Reports|February 19, 2019
Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis PatientsCsaba P Kovesdy, Christopher G Rowan, Ansgar Conrad, et al.
Pageof 4